Artiva Biotherapeutics (ARTV) Current Leases (2023 - 2025)
Historic Current Leases for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $3.1 million.
- Artiva Biotherapeutics' Current Leases fell 1430.55% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 1430.55%. This contributed to the annual value of $3.6 million for FY2024, which is 61.18% up from last year.
- Per Artiva Biotherapeutics' latest filing, its Current Leases stood at $3.1 million for Q3 2025, which was down 1430.55% from $3.5 million recorded in Q2 2025.
- In the past 5 years, Artiva Biotherapeutics' Current Leases ranged from a high of $3.7 million in Q2 2024 and a low of $3.1 million during Q3 2025
- Its 3-year average for Current Leases is $3.5 million, with a median of $3.6 million in 2023.
- In the last 5 years, Artiva Biotherapeutics' Current Leases soared by 61.18% in 2024 and then plummeted by 1430.55% in 2025.
- Over the past 3 years, Artiva Biotherapeutics' Current Leases (Quarter) stood at $3.6 million in 2023, then grew by 0.61% to $3.6 million in 2024, then fell by 14.4% to $3.1 million in 2025.
- Its Current Leases stands at $3.1 million for Q3 2025, versus $3.5 million for Q2 2025 and $3.6 million for Q1 2025.